Product Information
VENLAFAXINE HCL ER 75 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0794 per EA under NDC 00093738598. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 28, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093738598
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076565FDA Approved
6/28/2010
TE Code
AB
On Market Since
7/1/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 75 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 51.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0794 per EA |
|---|---|
| All-time high | $0.3054 (Mar 12, 2014) |
| All-time low | $0.0759 (Nov 20, 2024) |
| 52-week high | $0.0959 |
| 52-week low | $0.0794 |
| Median price | $0.1295 |
| Average price | $0.1320 |
| Largest weekly change | +45.6% (Feb 19, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 75 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.0794 per EA (NDC 00093738598), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 75 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 75 MG CAP has declined 51.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 75 MG CAP?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL ER 75 MG CAP has ranged from a low of $0.0759 (Nov 20, 2024) to a high of $0.3054 (Mar 12, 2014), with a median of $0.1295 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 75 MG CAP?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 75 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 75 MG CAP?
VENLAFAXINE HCL ER 75 MG CAP (NDC 00093738598) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.